Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Gemcitabine After Liver Transplantation for Proximal Bile Duct Cancer
DRKS00000805Phase 2Recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of gemcitabine in cholangiocarcinoma (CCA), extrahepatic cholangiocarcinoma (eCCA) and biliary cancer (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2012; status: recruiting.
02
Drugs
gemcitabine
03
Conditions
cholangiocarcinoma (CCA)extrahepatic cholangiocarcinoma (eCCA)biliary cancer
Beyond the preview
Go deeper on DRKS00000805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000805.